Sanzyme Biologics Private Limited, a active private limited company, was established on 16 September 2016 in Khairatabad, Telangana, India. Engaging in industrial enzymes & biochemicals within the manufacturing sector, it holds CIN: U24110TG2016PTC112002. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹4.00 Cr and a paid-up capital of ₹1.67 Cr.
It upholds a compliant status. Employing 303 professional, Its leadership includes Raunak Jay Soman (Whole-Time Director), Dhruv Jay Soman (Ceo), Jay Soman (Director). Past directors included Raunak Jay Soman, Dhruv Jay Soman. It holds no open charges and ₹6.50 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 2Nd Floor, Sattva Signature Tower,, #8-2-472/1/A/B/Sf-3, Road No. 1, Khairatabad, Telangana, 500034.
U24110TG2016PTC112002
112002
16 September 2016
₹4.00 Cr
₹1.67 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sanzyme Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raunak Jay Soman | Whole-Time Director | 21 Oct 2017 | Current |
| Dhruv Jay Soman | Ceo | 14 Sep 2023 | Current |
| Jay Soman | Director | 16 Sep 2016 | Current |
| Surapaneni Sree Rama Koteswara Rao | Director | 16 Sep 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 24 Sep 2018 | Past |
| Pramod Abcsdd | Director | 24 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sanzyme Biologics Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.75% decrease. The company also saw a substantial fall in profitability, with a 40.91% decrease in profit. The company's net worth Soared by an impressive increase of 12.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Sanzyme Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹65,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Apr 2018 | Others | ₹6.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Sanzyme Biologics has a workforce of 303 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sanzyme Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanzyme Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sanzyme Biologics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Sanzyme Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Progress on Dhruv Soman was appointed as a CEO was appointed as a CEO on 13 Oct 2023 & has been associated with this company since 2 years 1 month . was documented.
The activity Dhruv Jay Soman was appointed as a CEO was appointed as a CEO on 14 Sep 2023 & has been associated with this company since 2 years 2 months . was completed.
Progress on A charge registered on 10 Apr 2018 via Charge ID 100186783 with Others was fully satisfied on 23 Jan 2023. was documented.
A charge with Others of Rs. 6.50 Cr registered on 10 Apr 2018 with Charge ID 100186783 was modified on 23 Sep 2022. was recorded as a recent event.
The CIN of Sanzyme Biologics Private Limited is U24110TG2016PTC112002.
Sanzyme Biologics Private Limited is headquartered at 2Nd Floor, Sattva Signature Tower,, #8-2-472/1/A/B/Sf-3, Road No. 1, Khairatabad, Telangana, 500034.
Sanzyme Biologics Private Limited was incorporated on 16 September 2016.
The current directors of Sanzyme Biologics Private Limited are
The primary industry of Sanzyme Biologics Private Limited is Manufacturing.
Sanzyme Biologics Private Limited is unlisted.
The authorized capital of Sanzyme Biologics Private Limited is ₹4.00 Cr, and the paid-up capital is ₹1.67 Cr.
The compliance status of Sanzyme Biologics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX